Sangamo Taps Cytokinetics Exec Cockroft for Chief Medical Officer

Sangamo Therapeutics (NASDAQ: [[ticker:SGMO]]) has appointed Bettina Cockroft to serve as senior vice president and chief medical officer. Cockroft comes to Brisbane, CA-based Sangamo from Cytokinetics (NASDAQ: [[ticker:CYTK]]), where she was vice president of clinical research, neurology. Her experience also includes positions at Merck Serono, Novartis Consumer Health, and Menarini Ricerche. In July, Sangamo and partner Pfizer (NYSE: [[ticker:PFE]]) released data from an early stage study testing a gene therapy for hemophilia.

Author: Frank Vinluan

Xconomy Editor Frank Vinluan is a business journalist with experience covering technology and life sciences. Based in Raleigh, he was a staff writer at the Triangle Business Journal covering technology, biotechnology and energy before joining MedCityNews.com as North Carolina bureau chief. Prior to moving to North Carolina’s Research Triangle in 2007 he held business reporting positions at The Des Moines Register and The Seattle Times.